Decision: Favourable
Study Title:
LANDMARK Trial: A prospective, multinational, multicentre, open-label, randomised, non-inferiority trial to compare safety and effectiveness of Meril’s Myval
NREC Code:
22-NREC-MD-006
Decision:
Favourable
Meeting Date:
16/03/2022
Study Type:
MD application
Principal Investigator:
Dr Darren Mylotte
PI Institution:
Galway University Hospital
Sponsor:
Meril Life Sciences Pvt. Ltd